1
PET Study With [89Zr]-Df-CriPec® Docetaxel
Condition(s):Solid TumorLast Updated:October 8, 2020Completed
Docetaxel: 2554 Clinical Trials, Page 1 of 256
Hide Studies Not Open or Pending
2
Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis
Condition(s):Peritoneal CarcinomatosisLast Updated:November 23, 2020Recruiting
3
Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events
Condition(s):CYP3A Phenotyping; CYP3A5 and MDR1 Genotyping; Docetaxel Toxicity; Associations Between Genetic Data and Docetaxel ToxicityLast Updated:April 27, 2010Completed
4
A Study of CriPec® Docetaxel Given to Patients With Solid Tumours
Condition(s):Cancer; Metastatic Cancer; Solid TumorsLast Updated:September 24, 2018Completed
5
Docetaxel With or Without Bintrafusp Alfa for the Treatment of Advanced Non-small Cell Lung Cancer
Condition(s):Advanced Lung Non-Small Cell Carcinoma; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8Last Updated:December 10, 2020Recruiting
6
Docetaxel and Lycopene in Metastatic Prostate Cancer
Condition(s):Adenocarcinoma of the ProstateLast Updated:January 11, 2018Completed
7
Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients
Condition(s):Prostate CancerLast Updated:November 2, 2016Unknown status
8
Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer
Condition(s):Non-small Cell Lung CancerLast Updated:January 7, 2020Recruiting
9
A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors
Condition(s):Solid TumorLast Updated:May 17, 2017Completed
10
Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer
Condition(s):Pleural Effusion, Malignant; Non-small Cell CarcinomaLast Updated:March 8, 2019Completed